It is possible that tumor cells start upregulating IDO after TDO inhibitor treatment as a compensatory mechanism of Trp-Kyn pathway or in response to IFN-γ production by activated tumor-infiltrating T cells after blocking TDO. The gene discussed is IDO1; the disease is neoplasm.